Trial NCT01851408

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000480157
Secondary IDs: 2005-0215 N01CM62202 NCI-2009-00131

Last trial update was posted on 2015-04-15

MeSH Interventions

MTOR Inhibitors Sirolimus Sorafenib Temsirolimus

MeSH Conditions

Melanoma Recurrence

Other Conditions

Recurrent Melanoma Stage III Melanoma Stage IV Melanoma

Stopping Reasons

No progression of Phase 1 trial to Phase 2.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID